Alphadyne Asset Management’s AbbVie ABBV Stock Holding History

Alphadyne Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.64M	Sell	6,500 -15,100	-70%	-$3.25M	0.02%	506
2026 Q1	$4.7M	Sell	21,600 -5,200	-19%	-$1.15M	0.08%	301
2025 Q4	$6.12M	Buy	26,800 +17,400	+185%	+$3.96M	0.14%	109
2025 Q3	$2.18M	Buy	+9,400	New	+$1.91M	0.18%	131
2023 Q4	–	Sell	-44,800	Closed	-$6.68M	–	31
2023 Q3	$6.68M	Buy	44,800 +31,400	+234%	+$4.61M	0.51%	47
2023 Q2	$1.81M	Buy	+13,400	New	+$1.97M	0.22%	44

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Alphadyne Asset Management's ABBV Position: Q2 2026 in Review

Alphadyne Asset Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 3,940 shares — an estimated $848K sold.

Alphadyne Asset Management first reported a position in ABBV in Q2 2023 and held it in 3 quarters. The position peaked at $1.56M in Q3 2023. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Alphadyne Asset Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
Alphadyne Asset Management sold 3,940 AbbVie shares in Q2 2026, an estimated $848K.
Alphadyne Asset Management first reported a position in AbbVie in Q2 2023 and held it in 3 quarters.
Alphadyne Asset Management's AbbVie position peaked at $1.56M in Q3 2023.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Alphadyne Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.